ArticleJournal of the American Heart Association2016

Rapamycin Attenuates Cardiac Fibrosis in Experimental Uremic Cardiomyopathy by Reducing Marinobufagenin Levels and Inhibiting Downstream Pro-Fibrotic Signaling.

Steven T Haller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.